HIV-1 p24-specific B and T cell receptors (p24-specific BCR/TCR)

HIV-1 p24-specific B and T cell receptors are the specialized recognition molecules of the adaptive immune system that target the p24 capsid protein of the Human Immunodeficiency Virus type 1 (HIV-1). These receptors include B-cell receptors (BCRs), which are membrane-bound immunoglobulins that recognize p24 to initiate antibody production, and T-cell receptors (TCRs), which recognize p24-derived peptides presented by Major Histocompatibility Complex (MHC) molecules. The p24 protein is a highly conserved structural component of the viral core, making it a critical target for both natural immune control and therapeutic interventions. In clinical practice, the presence and magnitude of p24-specific immune responses are often used as indicators of the host's ability to control viral replication, with strong T-cell responses being a hallmark of elite controllers. Therapeutic vaccines and adoptive T-cell therapies are currently being developed to specifically activate or engineer these receptors to provide long-term viral suppression or a functional cure for HIV/AIDS. However, challenges such as viral mutational escape and T-cell exhaustion remain significant hurdles in effectively leveraging these receptors for treatment.

Other names

HIV-1 capsid protein-specific receptorsGag p24-specific BCRs and TCRsAnti-p24 immune receptorsp24-specific T-cell receptorsp24-specific B-cell receptors

Stimulation of antigen-specific immune responses through the binding of p24 epitopes to B-cell and T-cell receptors, leading to the destruction of HIV-infected cells and neutralization of the virus.